✦ LIBER ✦

Bioavailability of a controlled release indomethacin formulation in healthy subjects

✍ Scribed by B.W. Hadzija; E.K. Obeng; S.B. Ruddy; A. Noormohammadi; A.H. Beckett

Book ID: 113365617
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 626 KB
Volume: 67
Category: Article
ISSN: 0378-5173
DOI: 10.1016/0378-5173(91)90431-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bioavailability of indomethacin from two

Bioavailability of indomethacin from two multiple-units controlled-release formulations

✍ Helle Bechgaard; R. R. Brodie; L. F. Chasseaud; P. Houmøller; J. O. Hunter; P. S 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 709 KB

Study of the bioavailability of four ind

Study of the bioavailability of four indomethacin suppository formulations in healthy volunteers

✍ C De Muynck; R.A Lefebvre; J.P Remon 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 413 KB

Clinical bioavailability evaluation of a

Clinical bioavailability evaluation of a controlled release formulation of diazepam

✍ Jo H. Gustafson; Lester Weissman; Robert E. Weinfeld; Alice A. Holazo; Ko-Chin K 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 570 KB

A new topical formulation enhances relat

A new topical formulation enhances relative diclofenac bioavailability in healthy male subjects

✍ Martin Brunner; David Davies; Wolfgang Martin; Chiara Leuratti; Edith Lackner; M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Steady-state bioavailability of controll

Steady-state bioavailability of controlled-release oxycodone in normal subjects

✍ Robert F. Reder; Benjamin Oshlack; Jahanara B. Miotto; David D. Benziger; Robert 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 687 KB

A comparative bioavailability study on t

A comparative bioavailability study on two new sustained-release formulations of disodiummonofluorophosphate versus a nonsustained-release formulation in healthy volunteers

✍ L. Erlacher; H. Templ; D. Magometschnigg 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 436 KB

In 12 healthy volunteers the pharmacokinetic parameters of two new sustained-release formulations of disodiummonofluorophosphate (MFP) (B and C) were compared with those of a nonsustained-release reference preparation (A). This randomized study had a single-dose, triple-cross over design and consist